Virbac SACA

Virbac: Exceptional increase in revenue in the first half of 2021, with +21.3% at comparable exchange rates and scope (+14% at constant exchange rates and actual scope), driven by very solid performance in all areas and good market dynamics

20 Jul 2021 10:45:00 By Nasdaq GlobeNewswire

Virbac: driven by very solid performance in all areas and a very dynamic market, we are raising our outlook for 2021

05 Jul 2021 10:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights May 2021

18 Jun 2021 09:04:36 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights April 2021

05 May 2021 09:57:41 By Nasdaq GlobeNewswire

Virbac's 2020 Annual Financial Report

28 Apr 2021 08:36:39 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights March 2021

16 Apr 2021 11:38:25 By Nasdaq GlobeNewswire

Virbac: very strong growth in revenue in the first quarter of 2021 at +22.6% at comparable exchange rates and scope (+12.3% at constant rates), driven by very solid performance in all areas

15 Apr 2021 10:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights February 2021

22 Mar 2021 10:29:49 By Nasdaq GlobeNewswire

Virbac: 2020 current operating income showed strong growth (+37.6% at constant rates and scope), reflecting the excellent evolution of revenue (+5.7% at constant rates and scope) and a sharp decrease in expenses

17 Mar 2021 11:45:00 By Nasdaq GlobeNewswire

Virbac 2020 Year-end consolidated accounts

17 Mar 2021 11:35:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights January 2021

11 Feb 2021 10:24:07 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights December 2020

11 Feb 2021 10:17:54 By Nasdaq GlobeNewswire

VIRBAC:2020 annual revenue shows strong growth of +5.7% at constant exchange rates and scope (+3.2% at constant rates)

19 Jan 2021 10:45:00 By Nasdaq GlobeNewswire